This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-106a-5p | ABCA1 | 2.49 | 0 | -0.71 | 0.00276 | MirTarget; miRNATAP | -0.12 | 7.0E-5 | NA | |
2 | hsa-miR-106a-5p | ABCD2 | 2.49 | 0 | -3.08 | 0 | MirTarget | -0.35 | 0 | NA | |
3 | hsa-miR-106a-5p | ADAM19 | 2.49 | 0 | -1.06 | 0.01895 | mirMAP | -0.33 | 0 | NA | |
4 | hsa-miR-106a-5p | ADARB1 | 2.49 | 0 | -1.93 | 0 | MirTarget | -0.28 | 0 | NA | |
5 | hsa-miR-106a-5p | ADCY9 | 2.49 | 0 | -1.5 | 0 | mirMAP | -0.21 | 0 | NA | |
6 | hsa-miR-106a-5p | AHNAK | 2.49 | 0 | -1.66 | 0 | miRNATAP | -0.31 | 0 | NA | |
7 | hsa-miR-106a-5p | AKAP13 | 2.49 | 0 | -1.15 | 0 | MirTarget; mirMAP; miRNATAP | -0.17 | 0 | NA | |
8 | hsa-miR-106a-5p | AKT3 | 2.49 | 0 | -1.94 | 0 | miRNATAP | -0.24 | 0 | NA | |
9 | hsa-miR-106a-5p | ALPK3 | 2.49 | 0 | -1.02 | 0.00049 | mirMAP | -0.13 | 0.00095 | NA | |
10 | hsa-miR-106a-5p | ANK2 | 2.49 | 0 | -4.32 | 0 | MirTarget; miRNATAP | -0.38 | 0 | NA | |
11 | hsa-miR-106a-5p | ANKH | 2.49 | 0 | -0.38 | 0.21654 | MirTarget | -0.17 | 4.0E-5 | NA | |
12 | hsa-miR-106a-5p | ANKRD29 | 2.49 | 0 | -3.47 | 0 | MirTarget | -0.51 | 0 | NA | |
13 | hsa-miR-106a-5p | ANKRD50 | 2.49 | 0 | -0.88 | 0.00174 | MirTarget; miRNATAP | -0.11 | 0.0047 | NA | |
14 | hsa-miR-106a-5p | ANXA11 | 2.49 | 0 | -0.43 | 0.01849 | mirMAP | -0.12 | 0 | NA | |
15 | hsa-miR-106a-5p | APBB2 | 2.49 | 0 | -0.59 | 0.0014 | MirTarget; miRNATAP | -0.15 | 0 | NA | |
16 | hsa-miR-106a-5p | APP | 2.49 | 0 | -0.4 | 0.04288 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.14 | 0 | NA | |
17 | hsa-miR-106a-5p | ARHGAP1 | 2.49 | 0 | -0.88 | 0 | MirTarget; miRNATAP | -0.17 | 0 | NA | |
18 | hsa-miR-106a-5p | ARHGAP24 | 2.49 | 0 | -2.02 | 0 | MirTarget | -0.33 | 0 | NA | |
19 | hsa-miR-106a-5p | ARHGEF3 | 2.49 | 0 | -0.76 | 0 | MirTarget; miRNATAP | -0.12 | 0 | NA | |
20 | hsa-miR-106a-5p | ARL10 | 2.49 | 0 | -1.12 | 0.00198 | mirMAP | -0.2 | 2.0E-5 | NA | |
21 | hsa-miR-106a-5p | ARL4C | 2.49 | 0 | -0.28 | 0.33535 | MirTarget; miRNATAP | -0.22 | 0 | NA | |
22 | hsa-miR-106a-5p | ARL9 | 2.49 | 0 | -0.12 | 0.79825 | miRNAWalker2 validate | -0.13 | 0.03455 | NA | |
23 | hsa-miR-106a-5p | ARSB | 2.49 | 0 | -0.58 | 0.00052 | mirMAP | -0.15 | 0 | NA | |
24 | hsa-miR-106a-5p | ASPA | 2.49 | 0 | -4.76 | 0 | mirMAP | -0.26 | 0.001 | NA | |
25 | hsa-miR-106a-5p | ATE1 | 2.49 | 0 | -1.09 | 3.0E-5 | MirTarget | -0.11 | 0.00166 | NA | |
26 | hsa-miR-106a-5p | ATP1A2 | 2.49 | 0 | -6.96 | 0 | MirTarget | -0.8 | 0 | NA | |
27 | hsa-miR-106a-5p | ATXN1 | 2.49 | 0 | -1.51 | 0 | miRNATAP | -0.28 | 0 | NA | |
28 | hsa-miR-106a-5p | B3GALT2 | 2.49 | 0 | -3.85 | 0 | MirTarget | -0.28 | 0 | NA | |
29 | hsa-miR-106a-5p | BCL2L2 | 2.49 | 0 | -1.27 | 0 | miRNATAP | -0.1 | 1.0E-5 | NA | |
30 | hsa-miR-106a-5p | BMP2 | 2.49 | 0 | -1.46 | 0.00276 | miRNATAP | -0.14 | 0.03534 | NA | |
31 | hsa-miR-106a-5p | BMP7 | 2.49 | 0 | -1.78 | 0.02876 | mirMAP | -0.21 | 0.04978 | NA | |
32 | hsa-miR-106a-5p | BMPR2 | 2.49 | 0 | -0.59 | 4.0E-5 | MirTarget; miRNATAP | -0.13 | 0 | NA | |
33 | hsa-miR-106a-5p | BNC2 | 2.49 | 0 | -2.95 | 0 | miRNATAP | -0.6 | 0 | NA | |
34 | hsa-miR-106a-5p | C14orf28 | 2.49 | 0 | -0.89 | 0 | miRNATAP | -0.11 | 0 | NA | |
35 | hsa-miR-106a-5p | C3orf70 | 2.49 | 0 | -2.6 | 0 | miRNATAP | -0.12 | 0.02806 | NA | |
36 | hsa-miR-106a-5p | CALD1 | 2.49 | 0 | -2.47 | 0 | miRNATAP | -0.49 | 0 | NA | |
37 | hsa-miR-106a-5p | CBX7 | 2.49 | 0 | -2.55 | 0 | mirMAP | -0.22 | 0 | NA | |
38 | hsa-miR-106a-5p | CCBE1 | 2.49 | 0 | -1.07 | 0.09592 | mirMAP | -0.19 | 0.02573 | NA | |
39 | hsa-miR-106a-5p | CCND1 | 2.49 | 0 | 0.08 | 0.84033 | MirTarget; miRNATAP | -0.28 | 0 | NA | |
40 | hsa-miR-106a-5p | CCND2 | 2.49 | 0 | -2.43 | 0 | miRNATAP | -0.46 | 0 | NA | |
41 | hsa-miR-106a-5p | CD69 | 2.49 | 0 | -2.49 | 0 | miRNATAP | -0.35 | 0 | NA | |
42 | hsa-miR-106a-5p | CDK6 | 2.49 | 0 | -0.77 | 0.06479 | mirMAP | -0.24 | 2.0E-5 | NA | |
43 | hsa-miR-106a-5p | CDKN1A | 2.49 | 0 | -1.29 | 0 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.13 | 0.00055 | 25510666 | After prediction with online software we further used dual-luciferase reporter gene assay to ensure that TP53INP1 and CDKN1A might be the direct targets of miR-106a |
44 | hsa-miR-106a-5p | CELF2 | 2.49 | 0 | -3.05 | 0 | miRNATAP | -0.48 | 0 | NA | |
45 | hsa-miR-106a-5p | CERCAM | 2.49 | 0 | 0.21 | 0.50968 | MirTarget | -0.14 | 0.00074 | NA | |
46 | hsa-miR-106a-5p | CERK | 2.49 | 0 | -1.14 | 9.0E-5 | mirMAP | -0.15 | 0.00017 | NA | |
47 | hsa-miR-106a-5p | CFL2 | 2.49 | 0 | -2.62 | 0 | MirTarget; miRNATAP | -0.29 | 0 | NA | |
48 | hsa-miR-106a-5p | CHD5 | 2.49 | 0 | -3.46 | 0 | MirTarget; miRNATAP | -0.18 | 0.00312 | NA | |
49 | hsa-miR-106a-5p | CHD9 | 2.49 | 0 | -0.8 | 1.0E-5 | MirTarget; miRNATAP | -0.11 | 0 | NA | |
50 | hsa-miR-106a-5p | CLDN16 | 2.49 | 0 | 0.26 | 0.60929 | mirMAP | -0.14 | 0.04546 | NA | |
51 | hsa-miR-106a-5p | CLIP4 | 2.49 | 0 | -1.61 | 0 | MirTarget | -0.3 | 0 | NA | |
52 | hsa-miR-106a-5p | CNR2 | 2.49 | 0 | -2.05 | 6.0E-5 | mirMAP | -0.32 | 0 | NA | |
53 | hsa-miR-106a-5p | COL1A1 | 2.49 | 0 | -0.11 | 0.82007 | mirMAP | -0.44 | 0 | NA | |
54 | hsa-miR-106a-5p | COL8A2 | 2.49 | 0 | -1.27 | 0.00295 | mirMAP | -0.44 | 0 | NA | |
55 | hsa-miR-106a-5p | CORO2B | 2.49 | 0 | -2.03 | 0 | MirTarget; miRNATAP | -0.2 | 0.0007 | NA | |
56 | hsa-miR-106a-5p | CPEB3 | 2.49 | 0 | -1.3 | 0 | miRNATAP | -0.12 | 0 | NA | |
57 | hsa-miR-106a-5p | CPEB4 | 2.49 | 0 | -1.56 | 0 | mirMAP | -0.17 | 0 | NA | |
58 | hsa-miR-106a-5p | CPT1A | 2.49 | 0 | -0.83 | 0.00093 | mirMAP | -0.1 | 0.00197 | NA | |
59 | hsa-miR-106a-5p | CREB5 | 2.49 | 0 | -2.28 | 0 | MirTarget; miRNATAP | -0.28 | 0 | NA | |
60 | hsa-miR-106a-5p | CRIM1 | 2.49 | 0 | -0.45 | 0.0534 | MirTarget; miRNATAP | -0.11 | 0.00044 | NA | |
61 | hsa-miR-106a-5p | CRY2 | 2.49 | 0 | -1.68 | 0 | MirTarget; miRNATAP | -0.14 | 0 | NA | |
62 | hsa-miR-106a-5p | CRYBG3 | 2.49 | 0 | -1.11 | 5.0E-5 | MirTarget; miRNATAP | -0.22 | 0 | NA | |
63 | hsa-miR-106a-5p | CSF1 | 2.49 | 0 | -1.3 | 0.00033 | miRNATAP | -0.29 | 0 | NA | |
64 | hsa-miR-106a-5p | CSGALNACT1 | 2.49 | 0 | -2.42 | 0 | MirTarget | -0.24 | 0 | NA | |
65 | hsa-miR-106a-5p | CTSK | 2.49 | 0 | -1.41 | 0.00081 | MirTarget | -0.46 | 0 | NA | |
66 | hsa-miR-106a-5p | CXorf36 | 2.49 | 0 | -1.52 | 0 | mirMAP | -0.18 | 0 | NA | |
67 | hsa-miR-106a-5p | CYBRD1 | 2.49 | 0 | -2.55 | 0 | MirTarget | -0.41 | 0 | NA | |
68 | hsa-miR-106a-5p | CYP19A1 | 2.49 | 0 | -1.81 | 3.0E-5 | miRNAWalker2 validate | -0.27 | 0 | NA | |
69 | hsa-miR-106a-5p | DAB2 | 2.49 | 0 | -0.69 | 0.03265 | MirTarget; miRNATAP | -0.13 | 0.00261 | NA | |
70 | hsa-miR-106a-5p | DCBLD2 | 2.49 | 0 | -0.13 | 0.73597 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.11 | 0.03077 | NA | |
71 | hsa-miR-106a-5p | DIXDC1 | 2.49 | 0 | -3.01 | 0 | mirMAP | -0.39 | 0 | NA | |
72 | hsa-miR-106a-5p | DLG2 | 2.49 | 0 | -3.8 | 0 | mirMAP | -0.37 | 0 | NA | |
73 | hsa-miR-106a-5p | DMD | 2.49 | 0 | -3.69 | 0 | mirMAP | -0.45 | 0 | NA | |
74 | hsa-miR-106a-5p | DNAJB9 | 2.49 | 0 | -0.44 | 0.00239 | miRNATAP | -0.11 | 0 | NA | |
75 | hsa-miR-106a-5p | DPYD | 2.49 | 0 | -1.71 | 0.00028 | MirTarget | -0.47 | 0 | NA | |
76 | hsa-miR-106a-5p | DPYSL2 | 2.49 | 0 | -1.76 | 0 | MirTarget; miRNATAP | -0.24 | 0 | NA | |
77 | hsa-miR-106a-5p | DST | 2.49 | 0 | -1.12 | 9.0E-5 | mirMAP | -0.2 | 0 | NA | |
78 | hsa-miR-106a-5p | DUSP8 | 2.49 | 0 | -2.17 | 0 | MirTarget; miRNATAP | -0.17 | 0.00013 | NA | |
79 | hsa-miR-106a-5p | EDA2R | 2.49 | 0 | -1.5 | 0.00021 | MirTarget | -0.24 | 1.0E-5 | NA | |
80 | hsa-miR-106a-5p | EGR2 | 2.49 | 0 | -2.81 | 0 | MirTarget; miRNATAP | -0.35 | 0 | NA | |
81 | hsa-miR-106a-5p | EIF5A2 | 2.49 | 0 | -1.12 | 0.00497 | miRNATAP | -0.28 | 0 | NA | |
82 | hsa-miR-106a-5p | ELK3 | 2.49 | 0 | -0.31 | 0.25641 | MirTarget; miRNATAP | -0.18 | 0 | NA | |
83 | hsa-miR-106a-5p | ENPP1 | 2.49 | 0 | -2.1 | 0 | mirMAP | -0.34 | 0 | NA | |
84 | hsa-miR-106a-5p | ENTPD1 | 2.49 | 0 | -1.12 | 0 | mirMAP | -0.22 | 0 | NA | |
85 | hsa-miR-106a-5p | EPAS1 | 2.49 | 0 | -0.53 | 0.02805 | miRNATAP | -0.18 | 0 | NA | |
86 | hsa-miR-106a-5p | EPHA7 | 2.49 | 0 | -4.2 | 0 | miRNATAP | -0.27 | 0.00123 | NA | |
87 | hsa-miR-106a-5p | ETV1 | 2.49 | 0 | -0.69 | 0.03823 | MirTarget; miRNATAP | -0.26 | 0 | NA | |
88 | hsa-miR-106a-5p | F3 | 2.49 | 0 | -1.93 | 0.00015 | MirTarget; miRNATAP | -0.38 | 0 | NA | |
89 | hsa-miR-106a-5p | FAM46C | 2.49 | 0 | -1.66 | 0 | MirTarget; miRNATAP | -0.15 | 0.00033 | NA | |
90 | hsa-miR-106a-5p | FAS | 2.49 | 0 | -0.89 | 0.00676 | miRNAWalker2 validate; miRTarBase | -0.29 | 0 | 22431000; 27142596 | miR 106a is frequently upregulated in gastric cancer and inhibits the extrinsic apoptotic pathway by targeting FAS; Bioinformatic analysis combining with validation experiments identified FAS as a direct target of miR-106a; Moreover a significant inverse correlation was found between miR-106a and FAS expression not only in gastric cancer cell lines but also in gastric cancer specimens; Taken together these findings suggest that ectopicly overexpressed miR-106a may play an oncogenic role in gastric carcinogenesis and impair extrinsic apoptotic pathway through targeting FAS;Functional experiment ascertained that miR-106a interacted with FAS and mediated caspase3 pathway |
91 | hsa-miR-106a-5p | FAT2 | 2.49 | 0 | 0.77 | 0.30922 | MirTarget; miRNATAP | -0.29 | 0.00416 | NA | |
92 | hsa-miR-106a-5p | FAT4 | 2.49 | 0 | -2.57 | 0 | MirTarget; miRNATAP | -0.42 | 0 | NA | |
93 | hsa-miR-106a-5p | FBXO31 | 2.49 | 0 | -0.84 | 0 | MirTarget | -0.12 | 0 | NA | |
94 | hsa-miR-106a-5p | FGD5 | 2.49 | 0 | -1.17 | 0.00053 | MirTarget; miRNATAP | -0.21 | 0 | NA | |
95 | hsa-miR-106a-5p | FGFR1 | 2.49 | 0 | -2.88 | 0 | mirMAP | -0.38 | 0 | NA | |
96 | hsa-miR-106a-5p | FGL2 | 2.49 | 0 | -3.72 | 0 | MirTarget | -0.5 | 0 | NA | |
97 | hsa-miR-106a-5p | FHL2 | 2.49 | 0 | -0.45 | 0.13074 | mirMAP | -0.16 | 7.0E-5 | NA | |
98 | hsa-miR-106a-5p | FIBIN | 2.49 | 0 | -1.93 | 0.00102 | MirTarget | -0.62 | 0 | NA | |
99 | hsa-miR-106a-5p | FKBP5 | 2.49 | 0 | -1.54 | 4.0E-5 | mirMAP | -0.16 | 0.00182 | NA | |
100 | hsa-miR-106a-5p | FMN1 | 2.49 | 0 | -0.37 | 0.4819 | mirMAP | -0.16 | 0.02159 | NA | |
101 | hsa-miR-106a-5p | FNDC3A | 2.49 | 0 | -0.54 | 0.00477 | MirTarget; miRNATAP | -0.12 | 0 | NA | |
102 | hsa-miR-106a-5p | FOXN3 | 2.49 | 0 | -1.44 | 0 | miRNATAP | -0.11 | 1.0E-5 | NA | |
103 | hsa-miR-106a-5p | FRMD6 | 2.49 | 0 | -0.93 | 0.00183 | MirTarget; miRNATAP | -0.26 | 0 | NA | |
104 | hsa-miR-106a-5p | FYCO1 | 2.49 | 0 | -1.62 | 0 | MirTarget | -0.19 | 0 | NA | |
105 | hsa-miR-106a-5p | FYN | 2.49 | 0 | -1.47 | 0 | miRNATAP | -0.14 | 0.00023 | NA | |
106 | hsa-miR-106a-5p | GAS7 | 2.49 | 0 | -2.67 | 0 | mirMAP | -0.49 | 0 | NA | |
107 | hsa-miR-106a-5p | GBP4 | 2.49 | 0 | 0.37 | 0.3093 | mirMAP | -0.1 | 0.03283 | NA | |
108 | hsa-miR-106a-5p | GFRA1 | 2.49 | 0 | -5 | 0 | mirMAP | -0.45 | 0 | NA | |
109 | hsa-miR-106a-5p | GLIS3 | 2.49 | 0 | -0.79 | 0.02459 | miRNATAP | -0.2 | 1.0E-5 | NA | |
110 | hsa-miR-106a-5p | GM2A | 2.49 | 0 | 0.07 | 0.72789 | mirMAP | -0.12 | 3.0E-5 | NA | |
111 | hsa-miR-106a-5p | GPRC5A | 2.49 | 0 | -1.04 | 0.01909 | mirMAP | -0.2 | 0.00093 | NA | |
112 | hsa-miR-106a-5p | GREM2 | 2.49 | 0 | -4.99 | 0 | mirMAP | -0.44 | 0 | NA | |
113 | hsa-miR-106a-5p | GRM6 | 2.49 | 0 | -0.78 | 0.14738 | mirMAP | -0.15 | 0.0379 | NA | |
114 | hsa-miR-106a-5p | HABP4 | 2.49 | 0 | -1.4 | 0 | MirTarget; miRNATAP | -0.13 | 1.0E-5 | NA | |
115 | hsa-miR-106a-5p | HAS2 | 2.49 | 0 | -1.45 | 0.00631 | MirTarget | -0.26 | 0.00024 | NA | |
116 | hsa-miR-106a-5p | HDAC4 | 2.49 | 0 | -1.8 | 0 | mirMAP; miRNATAP | -0.14 | 0 | NA | |
117 | hsa-miR-106a-5p | HEG1 | 2.49 | 0 | -0.95 | 0.00135 | miRNATAP | -0.31 | 0 | NA | |
118 | hsa-miR-106a-5p | HES2 | 2.49 | 0 | 3.15 | 1.0E-5 | mirMAP | -0.23 | 0.02002 | NA | |
119 | hsa-miR-106a-5p | HFE | 2.49 | 0 | 0.04 | 0.89191 | mirMAP | -0.15 | 0.00043 | NA | |
120 | hsa-miR-106a-5p | HIPK3 | 2.49 | 0 | -1.75 | 0 | miRNAWalker2 validate; miRTarBase | -0.16 | 0.00101 | NA | |
121 | hsa-miR-106a-5p | HLF | 2.49 | 0 | -5.48 | 0 | MirTarget; miRNATAP | -0.49 | 0 | NA | |
122 | hsa-miR-106a-5p | IGSF10 | 2.49 | 0 | -5.3 | 0 | MirTarget | -0.35 | 0.0001 | NA | |
123 | hsa-miR-106a-5p | IL10 | 2.49 | 0 | -0.99 | 0.03081 | miRNAWalker2 validate | -0.29 | 0 | NA | |
124 | hsa-miR-106a-5p | IL1RAP | 2.49 | 0 | 0.69 | 0.05618 | MirTarget | -0.18 | 0.00011 | NA | |
125 | hsa-miR-106a-5p | IL6R | 2.49 | 0 | -1.87 | 0 | mirMAP | -0.19 | 0.0004 | NA | |
126 | hsa-miR-106a-5p | ISM1 | 2.49 | 0 | -0.18 | 0.67268 | miRNATAP | -0.28 | 0 | NA | |
127 | hsa-miR-106a-5p | ITPRIPL2 | 2.49 | 0 | -0.05 | 0.79208 | MirTarget; miRNATAP | -0.12 | 0 | NA | |
128 | hsa-miR-106a-5p | JAK1 | 2.49 | 0 | -0.65 | 0 | MirTarget | -0.13 | 0 | NA | |
129 | hsa-miR-106a-5p | JAM2 | 2.49 | 0 | -3.24 | 0 | miRNATAP | -0.44 | 0 | NA | |
130 | hsa-miR-106a-5p | JAZF1 | 2.49 | 0 | -1.92 | 0 | MirTarget; miRNATAP | -0.3 | 0 | NA | |
131 | hsa-miR-106a-5p | KATNAL1 | 2.49 | 0 | -1.58 | 1.0E-5 | MirTarget | -0.21 | 1.0E-5 | NA | |
132 | hsa-miR-106a-5p | KBTBD8 | 2.49 | 0 | -1.48 | 0 | MirTarget | -0.17 | 8.0E-5 | NA | |
133 | hsa-miR-106a-5p | KCND3 | 2.49 | 0 | -4.09 | 0 | mirMAP | -0.6 | 0 | NA | |
134 | hsa-miR-106a-5p | KCNMA1 | 2.49 | 0 | -3.78 | 0 | miRNATAP | -0.52 | 0 | NA | |
135 | hsa-miR-106a-5p | KIAA0513 | 2.49 | 0 | -1.87 | 0 | MirTarget; miRNATAP | -0.33 | 0 | NA | |
136 | hsa-miR-106a-5p | KIAA0922 | 2.49 | 0 | -1.16 | 0.00013 | MirTarget | -0.22 | 0 | NA | |
137 | hsa-miR-106a-5p | KIF13A | 2.49 | 0 | -1.22 | 0 | miRNATAP | -0.15 | 0 | NA | |
138 | hsa-miR-106a-5p | KIF26B | 2.49 | 0 | 2.26 | 0 | miRNATAP | -0.19 | 0.0006 | NA | |
139 | hsa-miR-106a-5p | KLF13 | 2.49 | 0 | -1.16 | 1.0E-5 | mirMAP | -0.13 | 0.00043 | NA | |
140 | hsa-miR-106a-5p | KLF9 | 2.49 | 0 | -2.79 | 0 | MirTarget; miRNATAP | -0.37 | 0 | NA | |
141 | hsa-miR-106a-5p | KLHL21 | 2.49 | 0 | -1.04 | 0 | mirMAP | -0.14 | 0 | NA | |
142 | hsa-miR-106a-5p | KPNA3 | 2.49 | 0 | -0.57 | 0.00262 | MirTarget; miRNATAP | -0.14 | 0 | NA | |
143 | hsa-miR-106a-5p | LAT2 | 2.49 | 0 | -0.57 | 0.08955 | mirMAP | -0.21 | 0 | NA | |
144 | hsa-miR-106a-5p | LDB3 | 2.49 | 0 | -3.79 | 0 | mirMAP | -0.37 | 0 | NA | |
145 | hsa-miR-106a-5p | LDLR | 2.49 | 0 | -1.42 | 7.0E-5 | miRNATAP | -0.15 | 0.00178 | NA | |
146 | hsa-miR-106a-5p | LHX6 | 2.49 | 0 | -0.89 | 0.00204 | MirTarget; miRNATAP | -0.12 | 0.00252 | NA | |
147 | hsa-miR-106a-5p | LIF | 2.49 | 0 | -1.63 | 3.0E-5 | miRNATAP | -0.18 | 0.00054 | NA | |
148 | hsa-miR-106a-5p | LIMA1 | 2.49 | 0 | -0.1 | 0.68612 | MirTarget; miRNATAP | -0.15 | 0 | NA | |
149 | hsa-miR-106a-5p | LMO3 | 2.49 | 0 | -4.72 | 0 | MirTarget; miRNATAP | -0.42 | 0 | NA | |
150 | hsa-miR-106a-5p | LPP | 2.49 | 0 | -2.04 | 0 | mirMAP | -0.26 | 0 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | REGULATION OF CELL DIFFERENTIATION | 58 | 1492 | 1.142e-11 | 4.375e-08 |
2 | CELL DEVELOPMENT | 56 | 1426 | 1.881e-11 | 4.375e-08 |
3 | REGULATION OF CELL DEVELOPMENT | 39 | 836 | 2.686e-10 | 3.124e-07 |
4 | TISSUE DEVELOPMENT | 56 | 1518 | 2.057e-10 | 3.124e-07 |
5 | NEUROGENESIS | 52 | 1402 | 8.562e-10 | 7.968e-07 |
6 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 57 | 1672 | 2.621e-09 | 2.033e-06 |
7 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 34 | 750 | 8.518e-09 | 5.662e-06 |
8 | RESPONSE TO ENDOGENOUS STIMULUS | 50 | 1450 | 2.08e-08 | 1.076e-05 |
9 | REGULATION OF NEURON DIFFERENTIATION | 28 | 554 | 1.979e-08 | 1.076e-05 |
10 | POSITIVE REGULATION OF GENE EXPRESSION | 56 | 1733 | 2.448e-08 | 1.139e-05 |
11 | MUSCLE STRUCTURE DEVELOPMENT | 24 | 432 | 3.678e-08 | 1.556e-05 |
12 | ORGAN MORPHOGENESIS | 35 | 841 | 4.313e-08 | 1.672e-05 |
13 | POSITIVE REGULATION OF CELL DEVELOPMENT | 25 | 472 | 4.797e-08 | 1.717e-05 |
14 | ORGAN GROWTH | 10 | 68 | 6.29e-08 | 2.044e-05 |
15 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 56 | 1784 | 6.59e-08 | 2.044e-05 |
16 | SKELETAL SYSTEM DEVELOPMENT | 24 | 455 | 9.71e-08 | 2.673e-05 |
17 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 56 | 1805 | 9.766e-08 | 2.673e-05 |
18 | NEURON DIFFERENTIATION | 35 | 874 | 1.101e-07 | 2.845e-05 |
19 | MUSCLE TISSUE DEVELOPMENT | 18 | 275 | 1.8e-07 | 3.653e-05 |
20 | POSITIVE REGULATION OF NEURON DIFFERENTIATION | 19 | 306 | 1.858e-07 | 3.653e-05 |
21 | POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 23 | 437 | 1.884e-07 | 3.653e-05 |
22 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 44 | 1275 | 1.632e-07 | 3.653e-05 |
23 | REGULATION OF SYSTEM PROCESS | 25 | 507 | 1.88e-07 | 3.653e-05 |
24 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 32 | 771 | 1.819e-07 | 3.653e-05 |
25 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 32 | 788 | 2.957e-07 | 5.292e-05 |
26 | CIRCULATORY SYSTEM DEVELOPMENT | 32 | 788 | 2.957e-07 | 5.292e-05 |
27 | REGULATION OF OSSIFICATION | 14 | 178 | 4.787e-07 | 8.25e-05 |
28 | MUSCLE CELL DIFFERENTIATION | 16 | 237 | 5.802e-07 | 9.309e-05 |
29 | RESPONSE TO ALCOHOL | 20 | 362 | 5.69e-07 | 9.309e-05 |
30 | BONE DEVELOPMENT | 13 | 156 | 6.38e-07 | 9.896e-05 |
31 | EPITHELIUM DEVELOPMENT | 35 | 945 | 6.95e-07 | 0.0001043 |
32 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 24 | 513 | 8.542e-07 | 0.0001242 |
33 | MESONEPHROS DEVELOPMENT | 10 | 90 | 9.273e-07 | 0.0001308 |
34 | MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 5 | 14 | 1.274e-06 | 0.0001703 |
35 | CARDIAC MUSCLE TISSUE DEVELOPMENT | 12 | 140 | 1.281e-06 | 0.0001703 |
36 | NEGATIVE REGULATION OF CELL DIFFERENTIATION | 26 | 609 | 1.637e-06 | 0.0002116 |
37 | RESPONSE TO STEROID HORMONE | 23 | 497 | 1.749e-06 | 0.0002142 |
38 | NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 35 | 983 | 1.708e-06 | 0.0002142 |
39 | CARTILAGE DEVELOPMENT | 12 | 147 | 2.148e-06 | 0.0002437 |
40 | SKELETAL SYSTEM MORPHOGENESIS | 14 | 201 | 2.055e-06 | 0.0002437 |
41 | REGULATION OF CELL PROLIFERATION | 46 | 1496 | 2.112e-06 | 0.0002437 |
42 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 53 | 1848 | 2.553e-06 | 0.0002828 |
43 | KIDNEY EPITHELIUM DEVELOPMENT | 11 | 125 | 2.75e-06 | 0.0002976 |
44 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 19 | 368 | 2.976e-06 | 0.0003147 |
45 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 18 | 337 | 3.396e-06 | 0.0003511 |
46 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 20 | 408 | 3.576e-06 | 0.0003617 |
47 | ENDOCHONDRAL BONE MORPHOGENESIS | 7 | 45 | 4.245e-06 | 0.0004203 |
48 | NEGATIVE REGULATION OF CELL PROLIFERATION | 26 | 643 | 4.391e-06 | 0.0004256 |
49 | NEURON DEVELOPMENT | 27 | 687 | 4.825e-06 | 0.0004581 |
50 | POSITIVE REGULATION OF LOCOMOTION | 20 | 420 | 5.514e-06 | 0.0005131 |
51 | OSSIFICATION | 15 | 251 | 5.891e-06 | 0.0005194 |
52 | NEGATIVE REGULATION OF PHOSPHORYLATION | 20 | 422 | 5.916e-06 | 0.0005194 |
53 | POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 12 | 162 | 5.906e-06 | 0.0005194 |
54 | NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 23 | 541 | 7.127e-06 | 0.0005712 |
55 | HEART DEVELOPMENT | 21 | 466 | 7.489e-06 | 0.0005712 |
56 | CONNECTIVE TISSUE DEVELOPMENT | 13 | 194 | 7.27e-06 | 0.0005712 |
57 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 34 | 1004 | 7.156e-06 | 0.0005712 |
58 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 37 | 1142 | 7.452e-06 | 0.0005712 |
59 | NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 23 | 541 | 7.127e-06 | 0.0005712 |
60 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 47 | 1618 | 7.45e-06 | 0.0005712 |
61 | DEVELOPMENTAL MATURATION | 13 | 193 | 6.874e-06 | 0.0005712 |
62 | VASCULATURE DEVELOPMENT | 21 | 469 | 8.256e-06 | 0.0006196 |
63 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 42 | 1395 | 1.038e-05 | 0.0007243 |
64 | NEURON PROJECTION MORPHOGENESIS | 19 | 402 | 1.054e-05 | 0.0007243 |
65 | TUBE DEVELOPMENT | 23 | 552 | 9.867e-06 | 0.0007243 |
66 | LOCOMOTION | 36 | 1114 | 1.058e-05 | 0.0007243 |
67 | RESPONSE TO GROWTH FACTOR | 21 | 475 | 1.001e-05 | 0.0007243 |
68 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 29 | 801 | 1.026e-05 | 0.0007243 |
69 | POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 14 | 232 | 1.08e-05 | 0.0007284 |
70 | RESPONSE TO HORMONE | 31 | 893 | 1.151e-05 | 0.0007642 |
71 | UROGENITAL SYSTEM DEVELOPMENT | 16 | 299 | 1.166e-05 | 0.0007642 |
72 | NEURON PROJECTION GUIDANCE | 13 | 205 | 1.317e-05 | 0.0008509 |
73 | CELLULAR COMPONENT MORPHOGENESIS | 31 | 900 | 1.341e-05 | 0.0008546 |
74 | REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL | 7 | 55 | 1.672e-05 | 0.001028 |
75 | CARDIAC MUSCLE CELL ACTION POTENTIAL | 6 | 37 | 1.64e-05 | 0.001028 |
76 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 29 | 823 | 1.7e-05 | 0.001028 |
77 | RESPONSE TO MECHANICAL STIMULUS | 13 | 210 | 1.702e-05 | 0.001028 |
78 | NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 27 | 740 | 1.833e-05 | 0.001093 |
79 | REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 38 | 1.923e-05 | 0.001119 |
80 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 30 | 872 | 1.903e-05 | 0.001119 |
81 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 33 | 1008 | 1.959e-05 | 0.001125 |
82 | CHEMICAL HOMEOSTASIS | 30 | 874 | 1.987e-05 | 0.001128 |
83 | MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 6 | 39 | 2.245e-05 | 0.001258 |
84 | BONE MORPHOGENESIS | 8 | 79 | 2.307e-05 | 0.001278 |
85 | NEURON PROJECTION DEVELOPMENT | 22 | 545 | 2.507e-05 | 0.001366 |
86 | RESPONSE TO ESTROGEN | 13 | 218 | 2.524e-05 | 0.001366 |
87 | REGULATION OF CELL ADHESION | 24 | 629 | 2.668e-05 | 0.001427 |
88 | RESPONSE TO DRUG | 19 | 431 | 2.768e-05 | 0.001464 |
89 | REGULATION OF PROTEIN MODIFICATION PROCESS | 47 | 1710 | 3.078e-05 | 0.001609 |
90 | REGULATION OF CELL PROJECTION ORGANIZATION | 22 | 558 | 3.574e-05 | 0.001831 |
91 | BLOOD VESSEL MORPHOGENESIS | 17 | 364 | 3.582e-05 | 0.001831 |
92 | POSITIVE REGULATION OF CELL PROLIFERATION | 28 | 814 | 3.664e-05 | 0.001853 |
93 | INTRACELLULAR SIGNAL TRANSDUCTION | 44 | 1572 | 3.721e-05 | 0.001862 |
94 | HEART PROCESS | 8 | 85 | 3.94e-05 | 0.001934 |
95 | REGULATION OF BLOOD CIRCULATION | 15 | 295 | 3.948e-05 | 0.001934 |
96 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 40 | 1381 | 4.135e-05 | 0.002004 |
97 | DEVELOPMENTAL GROWTH | 16 | 333 | 4.333e-05 | 0.002079 |
98 | GROWTH | 18 | 410 | 4.748e-05 | 0.002254 |
99 | TISSUE MORPHOGENESIS | 21 | 533 | 5.438e-05 | 0.002503 |
100 | SENSORY ORGAN DEVELOPMENT | 20 | 493 | 5.486e-05 | 0.002503 |
101 | NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 23 | 616 | 5.483e-05 | 0.002503 |
102 | POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 15 | 303 | 5.355e-05 | 0.002503 |
103 | STRIATED MUSCLE CELL DIFFERENTIATION | 11 | 173 | 5.94e-05 | 0.002683 |
104 | REGULATION OF MEMBRANE POTENTIAL | 16 | 343 | 6.156e-05 | 0.002754 |
105 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 27 | 799 | 6.839e-05 | 0.003031 |
106 | REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 6 | 48 | 7.545e-05 | 0.003312 |
107 | RESPONSE TO BMP | 8 | 94 | 8.118e-05 | 0.003498 |
108 | CELLULAR RESPONSE TO BMP STIMULUS | 8 | 94 | 8.118e-05 | 0.003498 |
109 | REGULATION OF CHEMOTAXIS | 11 | 180 | 8.492e-05 | 0.003625 |
110 | REGULATION OF CELL MORPHOGENESIS | 21 | 552 | 8.924e-05 | 0.003775 |
111 | MULTICELLULAR ORGANISMAL SIGNALING | 9 | 123 | 9.572e-05 | 0.004012 |
112 | METANEPHRIC NEPHRON DEVELOPMENT | 5 | 32 | 0.0001028 | 0.004271 |
113 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 24 | 689 | 0.0001106 | 0.004555 |
114 | POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 34 | 1152 | 0.0001143 | 0.004667 |
115 | REGULATION OF METAL ION TRANSPORT | 15 | 325 | 0.0001172 | 0.004702 |
116 | POSITIVE REGULATION OF CELL DEATH | 22 | 605 | 0.0001167 | 0.004702 |
117 | REGULATION OF HEART CONTRACTION | 12 | 221 | 0.0001263 | 0.005002 |
118 | REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 7 | 75 | 0.0001269 | 0.005002 |
119 | MUSCLE CELL DEVELOPMENT | 9 | 128 | 0.00013 | 0.005082 |
120 | MESONEPHRIC TUBULE MORPHOGENESIS | 6 | 53 | 0.0001326 | 0.005142 |
121 | EMBRYONIC ORGAN DEVELOPMENT | 17 | 406 | 0.0001363 | 0.005241 |
122 | RESPONSE TO FLUID SHEAR STRESS | 5 | 34 | 0.0001386 | 0.005288 |
123 | RESPONSE TO EXTERNAL STIMULUS | 47 | 1821 | 0.000141 | 0.005332 |
124 | CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 4 | 19 | 0.0001569 | 0.005888 |
125 | RESPONSE TO LIPID | 28 | 888 | 0.0001617 | 0.006019 |
126 | BIOLOGICAL ADHESION | 31 | 1032 | 0.0001706 | 0.006301 |
127 | DENDRITE DEVELOPMENT | 7 | 79 | 0.0001761 | 0.006453 |
128 | CELLULAR RESPONSE TO LIPID | 18 | 457 | 0.0001861 | 0.006764 |
129 | BONE GROWTH | 4 | 20 | 0.0001938 | 0.006992 |
130 | EXTRACELLULAR STRUCTURE ORGANIZATION | 14 | 304 | 0.0002015 | 0.007211 |
131 | HOMEOSTATIC PROCESS | 37 | 1337 | 0.0002055 | 0.007301 |
132 | MORPHOGENESIS OF A BRANCHING STRUCTURE | 10 | 167 | 0.0002095 | 0.007385 |
133 | NEGATIVE REGULATION OF GENE EXPRESSION | 40 | 1493 | 0.0002193 | 0.007671 |
134 | TAXIS | 18 | 464 | 0.000224 | 0.007778 |
135 | REGULATION OF ION TRANSPORT | 21 | 592 | 0.0002332 | 0.008037 |
136 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 43 | 1656 | 0.0002462 | 0.008424 |
137 | CHONDROCYTE DIFFERENTIATION | 6 | 60 | 0.0002651 | 0.008899 |
138 | REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION | 6 | 60 | 0.0002651 | 0.008899 |
139 | REGULATION OF CELL SIZE | 10 | 172 | 0.0002658 | 0.008899 |
140 | TRABECULA MORPHOGENESIS | 5 | 39 | 0.0002699 | 0.008972 |
141 | RESPONSE TO ORGANIC CYCLIC COMPOUND | 28 | 917 | 0.0002733 | 0.00902 |
142 | REGULATION OF OSTEOBLAST DIFFERENTIATION | 8 | 112 | 0.0002754 | 0.009023 |
143 | MUSCLE ORGAN DEVELOPMENT | 13 | 277 | 0.000282 | 0.009177 |
144 | MEMBRANE DEPOLARIZATION | 6 | 61 | 0.0002904 | 0.00932 |
145 | NEGATIVE REGULATION OF CELL CYCLE | 17 | 433 | 0.0002904 | 0.00932 |
146 | REGULATION OF CATION TRANSMEMBRANE TRANSPORT | 11 | 208 | 0.0003014 | 0.009604 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | VOLTAGE GATED SODIUM CHANNEL ACTIVITY | 5 | 20 | 9.164e-06 | 0.008513 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | INTRINSIC COMPONENT OF PLASMA MEMBRANE | 55 | 1649 | 1.135e-08 | 6.627e-06 |
2 | MEMBRANE MICRODOMAIN | 18 | 288 | 3.567e-07 | 0.0001042 |
3 | CONTRACTILE FIBER | 14 | 211 | 3.631e-06 | 0.0005301 |
4 | SARCOLEMMA | 11 | 125 | 2.75e-06 | 0.0005301 |
5 | I BAND | 10 | 121 | 1.367e-05 | 0.001513 |
6 | MEMBRANE REGION | 36 | 1134 | 1.554e-05 | 0.001513 |
7 | ACTIN CYTOSKELETON | 19 | 444 | 4.142e-05 | 0.003137 |
8 | VOLTAGE GATED SODIUM CHANNEL COMPLEX | 4 | 14 | 4.298e-05 | 0.003137 |
9 | BASAL PLASMA MEMBRANE | 5 | 33 | 0.0001197 | 0.004993 |
10 | SODIUM CHANNEL COMPLEX | 4 | 17 | 9.864e-05 | 0.004993 |
11 | CELL JUNCTION | 34 | 1151 | 0.0001125 | 0.004993 |
12 | BASAL PART OF CELL | 6 | 51 | 0.0001067 | 0.004993 |
13 | PLASMA MEMBRANE PROTEIN COMPLEX | 20 | 510 | 8.725e-05 | 0.004993 |
14 | CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 5 | 31 | 8.781e-05 | 0.004993 |
15 | CYTOSKELETON | 49 | 1967 | 0.0002328 | 0.009062 |
16 | SIDE OF MEMBRANE | 17 | 428 | 0.0002538 | 0.009265 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | FoxO_signaling_pathway_hsa04068 | 11 | 132 | 4.682e-06 | 0.0002435 | |
2 | Hippo_signaling_pathway_hsa04390 | 11 | 154 | 2.035e-05 | 0.0005033 | |
3 | Cellular_senescence_hsa04218 | 11 | 160 | 2.904e-05 | 0.0005033 | |
4 | p53_signaling_pathway_hsa04115 | 7 | 68 | 6.771e-05 | 0.0008802 | |
5 | Jak_STAT_signaling_pathway_hsa04630 | 10 | 162 | 0.0001636 | 0.001701 | |
6 | Cytokine_cytokine_receptor_interaction_hsa04060 | 13 | 270 | 0.0002201 | 0.001908 | |
7 | PI3K_Akt_signaling_pathway_hsa04151 | 14 | 352 | 0.0008677 | 0.006446 | |
8 | TGF_beta_signaling_pathway_hsa04350 | 6 | 84 | 0.001598 | 0.01039 | |
9 | TNF_signaling_pathway_hsa04668 | 6 | 108 | 0.0056 | 0.03236 | |
10 | Hippo_signaling_pathway_multiple_species_hsa04392 | 3 | 29 | 0.008985 | 0.04672 | |
11 | Focal_adhesion_hsa04510 | 8 | 199 | 0.01016 | 0.04801 | |
12 | MAPK_signaling_pathway_hsa04010 | 10 | 295 | 0.01341 | 0.05809 | |
13 | Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 | 6 | 139 | 0.018 | 0.072 | |
14 | Adherens_junction_hsa04520 | 4 | 72 | 0.02253 | 0.08367 | |
15 | AMPK_signaling_pathway_hsa04152 | 5 | 121 | 0.03495 | 0.1104 | |
16 | cGMP_PKG_signaling_pathway_hsa04022 | 6 | 163 | 0.03559 | 0.1104 | |
17 | Cell_cycle_hsa04110 | 5 | 124 | 0.03821 | 0.1104 | |
18 | Oocyte_meiosis_hsa04114 | 5 | 124 | 0.03821 | 0.1104 | |
19 | HIF_1_signaling_pathway_hsa04066 | 4 | 100 | 0.06251 | 0.1711 | |
20 | Phospholipase_D_signaling_pathway_hsa04072 | 5 | 146 | 0.0677 | 0.176 | |
21 | Sphingolipid_signaling_pathway_hsa04071 | 4 | 118 | 0.1 | 0.2477 | |
22 | Ferroptosis_hsa04216 | 2 | 40 | 0.1194 | 0.2795 | |
23 | ECM_receptor_interaction_hsa04512 | 3 | 82 | 0.1236 | 0.2795 | |
24 | Ras_signaling_pathway_hsa04014 | 6 | 232 | 0.134 | 0.2832 | |
25 | Calcium_signaling_pathway_hsa04020 | 5 | 182 | 0.1365 | 0.2832 | |
26 | ABC_transporters_hsa02010 | 2 | 45 | 0.1446 | 0.2832 | |
27 | Apelin_signaling_pathway_hsa04371 | 4 | 137 | 0.1485 | 0.2832 | |
28 | Hedgehog_signaling_pathway_hsa04340 | 2 | 47 | 0.155 | 0.2832 | |
29 | Endocytosis_hsa04144 | 6 | 244 | 0.1582 | 0.2832 | |
30 | Cell_adhesion_molecules_.CAMs._hsa04514 | 4 | 145 | 0.1711 | 0.2832 | |
31 | Wnt_signaling_pathway_hsa04310 | 4 | 146 | 0.174 | 0.2832 | |
32 | cAMP_signaling_pathway_hsa04024 | 5 | 198 | 0.1743 | 0.2832 | |
33 | Rap1_signaling_pathway_hsa04015 | 5 | 206 | 0.1945 | 0.3064 | |
34 | VEGF_signaling_pathway_hsa04370 | 2 | 59 | 0.2195 | 0.3357 | |
35 | Tight_junction_hsa04530 | 4 | 170 | 0.2483 | 0.3689 | |
36 | Lysosome_hsa04142 | 3 | 123 | 0.2777 | 0.4011 | |
37 | Autophagy_animal_hsa04140 | 3 | 128 | 0.2979 | 0.4187 | |
38 | Apoptosis_hsa04210 | 3 | 138 | 0.3387 | 0.4635 | |
39 | ErbB_signaling_pathway_hsa04012 | 2 | 85 | 0.3622 | 0.4797 | |
40 | Regulation_of_actin_cytoskeleton_hsa04810 | 4 | 208 | 0.3752 | 0.4797 | |
41 | Gap_junction_hsa04540 | 2 | 88 | 0.3782 | 0.4797 | |
42 | Phosphatidylinositol_signaling_system_hsa04070 | 2 | 99 | 0.4354 | 0.5357 | |
43 | Necroptosis_hsa04217 | 3 | 164 | 0.443 | 0.5357 | |
44 | Neuroactive_ligand_receptor_interaction_hsa04080 | 4 | 278 | 0.5969 | 0.7054 | |
45 | mTOR_signaling_pathway_hsa04150 | 2 | 151 | 0.6608 | 0.7636 |